China SXT Pharmaceuticals, Inc. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
China SXT Pharmaceuticals, Inc. (SXTC) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of -$203.74 thousand as of 2022-09-30, per its 6-K filed 2023-02-24.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2023-02-24
- 2022-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net -$203.74K.
- 2022-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net -$769.90K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2022-09-30 | -$203.74K 6-K · filed 2023-02-24 |
| 2022-03-31 | -$769.90K 6-K · filed 2023-02-24 |